GPER1 and colorectal carcinoma: In contrast, analysis of The Cancer Genome Atlas dataset revealed that high expression of GPER was significantly associated with survival in female CRC patients at stage III-IV but not in female CRC patients at stage I-II or male CRC patients at any stage [35, 37–39].